Mars Bioimaging

About:

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical

Website: http://www.marsbioimaging.com

Twitter/X: marsbioimaging

Top Investors: Powerhouse Ventures

Description:

Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its applications in medical diagnosis. The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.

Total Funding Amount:

$500000

Headquarters Location:

Christchurch, Canterbury, New Zealand

Founded Date:

2007-01-01

Contact Email:

spectroscopy(AT)marsbioimaging.com

Founders:

Phil Butler

Number of Employees:

11-50

Last Funding Date:

2014-02-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai